-
Brazil's imprisoned Bolsonaro hospitalized ahead of surgery
-
Serbia court drops case against ex-minister over train station disaster
-
Investors watching for Santa rally in thin pre-Christmas trade
-
David Sacks: Trump's AI power broker
-
Delap and Estevao in line for Chelsea return against Aston Villa
-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
SMX Is Transitioning From Single Deployments to Supply-Chain Infrastructure
-
Each SMX Partnership Opens a Market, the Portfolio Multiplies the Value
-
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
-
Why SMX's Partnerships Expand Value Faster Than Its Cost Base
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
| RYCEF | 1.29% | 15.56 | $ | |
| CMSC | 0.3% | 23.08 | $ | |
| VOD | 0.16% | 13.081 | $ | |
| RIO | -0.56% | 80.52 | $ | |
| NGG | 0.17% | 77.37 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| BTI | 0.25% | 57.185 | $ | |
| GSK | 0.19% | 48.945 | $ | |
| AZN | 0.43% | 92.54 | $ | |
| CMSD | 0.13% | 23.05 | $ | |
| RELX | -0.06% | 41.105 | $ | |
| BCE | 0.63% | 22.875 | $ | |
| JRI | 0.28% | 13.448 | $ | |
| BP | -0.73% | 34.329 | $ | |
| BCC | 1.55% | 74.38 | $ | |
| RBGPF | 1.28% | 81.26 | $ |
Trump orders curb on virus research he blames for Covid pandemic
US President Donald Trump on Monday ordered new limitations on a form of biological research his administration says caused the Covid-19 pandemic through a lab leak in China.
The United States will halt funding in certain countries for so-called "gain-of-function" experiments -- aimed at enhancing the properties of pathogens —- according to an executive order Trump signed Monday at the White House.
"There's no laboratory that's immune from leaks -- and this is going to prevent inadvertent leaks from happening in the future and endangering humanity," Health Secretary Robert F. Kennedy Jr. wrote on X.
"Any nation that engages in this research endangers their own population, as well as the world, as we saw during the COVID pandemic," added Jay Bhattacharya, director of the National Institutes of Health.
Trump has long championed the theory that SARS-CoV-2 leaked from the Wuhan Institute of Virology as a result of gain-of-function research -- an alternative to the theory that the virus spilled over naturally from wild animals to humans at a seafood market in the same city.
The US government website Covid.gov, which previously focused on promoting vaccine and testing information, is now devoted to highlighting arguments that favor the lab leak.
Several US agencies, including the Federal Bureau of Investigation, the Department of Energy, and, most recently, the Central Intelligence Agency -- which shifted its stance under Trump's second term -- now lean toward a lab origin. Several other intelligence agencies favor natural spillover.
During the 2010s, the National Institutes of Health funded bat coronavirus research at the Wuhan Institute via the US-based nonprofit EcoHealth Alliance -- a grant axed by Trump in 2020 during his first term, but later partially restored under president Joe Biden.
Complicating matters, former top infectious disease official Anthony Fauci has maintained that the work in Wuhan did not meet the federal definition of gain-of-function, though some virologists and US officials have disputed that claim.
Trump's order names China as an example of a "country of concern" where such research should not be supported.
The order also seeks to end funding for other types of life sciences research in countries deemed to lack sufficient oversight, significantly broadening the types of foreign research that could be targeted.
It further calls for the development of a strategy to "govern, limit, and track dangerous gain-of-function research across the United States that occurs without federal funding" -- though the extent of the government's control over non-federal research is unclear, and the order also calls for new legislation to fill any gaps.
Trump's executive order comes amid broader efforts by his administration to reshape American science and health policy, including mass firings to government scientists and steep slashes to research budgets.
P.Stevenson--AMWN